Emerging Leader CardioWise is a small, Venture-ready medical imaging software company that recently appointed a new CEO and board member, signaling leadership execution focus and potential for accelerated go-to-market strategies and Investor engagement.

AI Cardiology The company markets an AI-powered non-invasive cardiac CT analysis platform with 3D heart modeling, presenting a compelling expansion pathway to healthcare providers seeking advanced diagnostic tooling and workflow efficiencies.

Regulatory Milestone Achievement of FDA 510(k) clearance for SQuEEZ underscores regulatory readiness and product legitimacy, creating a credible entry point for hospital systems and imaging centers that require compliant solutions.

Strategic Partnerships Recognition by UCSF Health Hub, Edison Accelerator in Canada, and engagement with GE Healthcare and Nex Cubed indicate a strong partner network and potential co-sell or integration opportunities to scale adoption.

Growth Opportunity Current funding and modest revenue range suggest an opportunity to upsell to mid-to-large radiology groups and imaging centers, leveraging events like InvestMidwest and venture-backed exposure to attract additional customers and channel partners.